Spiro George Rombotis, President and CEO at Cyclacel Pharmaceuticals, Inc. (CYCC), bought 4,000 shares at $4.50 ($18K) on 2021-11-18, disclosed to the SEC on 2021-11-22.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| CYCC | BUY | 2011-12-27 | $8K | — | Filing → |
| CYCC | BUY | 2011-09-26 | $15K | — | Filing → |
| CYCC | BUY | 2011-09-14 | $8K | — | Filing → |